UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

 

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number  000-53071

 

TARGETED MEDICAL PHARMA, INC.

 

(Exact name of registrant as specified in its charter)

 

2980 BEVERLY GLEN CIRCLE, SUITE 100

LOS ANGELES, CA 90077

(310) 474-9808

 

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock

 

(Title of each class of securities covered by this Form)

 

None

 

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

  Rule 12g-4(a)(1) x
     
  Rule 12g-4(a)(2) ¨
     
  Rule 12h-3(b)(1)(i) ¨
     
  Rule 12h-3(b)(1)(ii) ¨
     
  Rule 15d-6 ¨

 

Approximate number of holders of record as of the certification or notice date:   289

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Targeted Medical Pharma, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:   October 18, 2018   By: /s/ Marcus Charuvastra
        Marcus Charuvastra
Interim Chief Executive Officer

 

 

 

Targeted Medical Pharma (PK) (USOTC:TRGM)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Targeted Medical Pharma (PK) Charts.
Targeted Medical Pharma (PK) (USOTC:TRGM)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Targeted Medical Pharma (PK) Charts.